"Precision Insights for Legal Updates"
Recent legal developments illustrate a dynamic landscape shaped by significant rulings, changes in regulatory frameworks, and emerging industry-specific trends. Particularly notable are the Fifth Circuit's action regarding the Federal Trade Commission's (FTC) Hart-Scott-Rodino (HSR) filing requirements, a landmark Texas Supreme Court ruling on indemnification agreements, and ongoing public and legal debates surrounding emerging technologies and their implications on existing laws. These developments not only reflect shifts in judicial sentiment but also underscore the challenges faced by various sectors in navigating evolving legal expectations.
The Fifth Circuit has vacated the FTC's new HSR form effectively, marking a significant change in how mergers and acquisitions might be assessed going forward. With this change, businesses must reassess their compliance processes to align with the reinstated older HSR rules. This decision comes amidst broader scrutiny of regulatory practices, suggesting a potential recalibration of antitrust evaluations that could significantly influence corporate consolidation strategies. The uncertainty surrounding the new HSR form, which was intended to heighten scrutiny on mergers potentially harmful to competition, raises questions about how enforcement will proceed under the older framework.
Meanwhile, the Texas Supreme Court's ruling regarding proportional indemnification agreements is a pivotal development for liability and settlement negotiations. The court determined that such agreements can survive the settlement of claims, allowing parties to retain indemnification rights even when resolving disputes. This ruling strengthens the legal standing of insurers and contractors engaged in agreements related to indemnification, ultimately reinforcing contractual protections in commercial dealings and liability contexts across Texas.
The recent scrutiny by the Small Business Administration (SBA) over the oversight and eligibility of the 8(a) business development program is an important compliance update for businesses seeking federal contracts. This latest audit plan signals a focused effort to ensure that eligibility criteria are strictly adhered to, particularly in the wake of prior audits that raised concerns about potential abuses of the program. Companies involved in federal contracting should review their operations and ensure compliance with eligibility requirements to mitigate risks of disqualification or penalties.
At the same time, there are ongoing challenges to the regulatory landscape concerning dual-currency game models within various states. Prohibitive measures against these models reflect heightened concerns about fairness and the potential for exploitation in gaming environments. Stakeholders within the gaming sector should remain vigilant regarding these regulations, adapting their business models to comply with state laws while exploring innovative alternatives to enhance their offerings.
The Texas Supreme Court's affirmation of the enforceability of proportional indemnification agreements not only has direct implications for litigants in Texas but also sets a precedent that could influence similar rulings in other jurisdictions. This outcome underscores the importance of carefully drafting indemnification clauses within contracts, as the potential for enforceability post-settlement can impact liability strategies significantly. Businesses, especially those operating in sectors with heightened litigation risks, should proactively update their agreements to reflect this judicial trend.
In the realm of healthcare, emerging lawsuits linking GLP-1 medications such as Ozempic and Wegovy to serious side effects like vision loss present critical legal challenges for pharmaceutical companies. These lawsuits may encourage increased scrutiny regarding the safety and marketing practices of new drugs, leading to a possible shift in regulatory attention toward better consumer protection mechanisms. As more such lawsuits are anticipated, companies in this space must devise robust risk management and legal strategies to navigate potential liabilities.
Additionally, the anticipated impact of artificial intelligence on trade secret litigation signals a transformative shift. As AI technologies become more prevalent, the legal treatment of trade secrets related to these innovations is likely to evolve, prompting industries to reconsider how they protect their proprietary information in an increasingly competitive environment. Companies must stay ahead of these trends to ensure their trade secret protections remain effective and compliant.
- **Review Compliance Protocols**: Reassess merger and acquisition operations in light of the vacated HSR form to align with previous regulations.
- **Update Indemnification Agreements**: Re-evaluate and amend indemnification agreements to leverage the Texas Supreme Court ruling in negotiating future settlements.
- **Audit Federal Contracting Practices**: Conduct internal audits to ensure compliance with SBA's oversight on the 8(a) program eligibility.
- **Monitor Litigation Trends**: Stay informed about emerging lawsuits concerning health products and AI-related trade secrets to proactively mitigate risks.
Following a series of procedural rulings, the FTC’s significant revisions in early 2025 to the HSR Notification and Report Form have been vacated and are no longer in effect....By: Fenwick & West LLP
On March 9, 2026, the Department of Health and Human Services Office of Inspector General (“OIG”) posted an advisory opinion addressing a medical technology manufacturer and distributor’s proposal to offer ambulatory surgery centers (“ASCs”) a discount on (“IOLs”) and other surgical supplies used to
The Texas Supreme Court recently provided contractors and their insurers a new pathway to recover settlement dollars via proportionate indemnity clauses, which are routinely found in construction and energy contracts. In a March 13, 2026 decision, the Court determined that indemnity rights can survi
Patients who were prescribed Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), or other GLP-1 receptor agonist medications to treat type 2 diabetes or for weight loss may be at risk of vision loss or blindness from a condition known as non-arteritic anterior ischemic optic neuropa
The California State University system joins a short list of universities fighting Trump orders in court. The Education Department has threatened to cut federal funds to San Jose State University.
Maria Kalesnikava is campaigning for the West to engage with the regime in Belarus that imprisoned her for more than five years.
Just as practitioners may feel adjusted to the surge of trade secrets litigation over the last decade, artificial intelligence (AI) is reshaping the landscape in ways that will likely prompt companies and courts to rethink long-standing assumptions....By: DLA Piper
As of today, the “new” HSR rules that took effect on February 10, 2025 are no longer in effect. Yesterday, the Fifth Circuit denied the FTC’s motion to stay the district court’s order vacating the new HSR rules on the grounds that they exceeded the FTC’s authority....By: Fried Frank
Recent changes in state laws call into question what constitutes “gambling” and could have significant implications for gaming operators....By: DLA Piper
On March 17, 2026, the Small Business Administration (“SBA”) announced the audit and review priorities of the SBA’s Office of Inspector General. According to the SBA, the announced priorities “includes planned audits, evaluations, and reviews focused on promoting the economy, efficiency, and effecti